Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Are Bulk Purchase Annuity Buy-Ins Set to Feature More Often in the US Pension Risk Transfer Market?

    Longevity and Mortality Risk Transfer October 22, 2025By Mark McCord
    Share
    Twitter LinkedIn Email

    The number of bulk purchase annuity buy-ins in the US pension risk transfer (PRT) market remains small in both absolute and relative terms despite recent signals of interest in these deals. 

    The strict ERISA requirement for US plan sponsors to select the “safest available annuity provider” when transferring liabilities has also mitigated against other strategies because the standard is best met by the final, permanent nature of a full scheme buy-out.  

    This nuance is illustrated starkly in industry data. According to LIMRA, in 2024, only 10 buy-in contracts were sold, up from 8 contracts in 2023, and aggregate buy-in premium totaled $3.7bn for the year, down 5% from 2023 and representing just 7% of the $52bn of aggregate premium seen last year. 

    Although buy-ins don’t offer the same benefit as buy-outs – i.e., a full termination of the pension plan – they can be completed much quicker, and give sponsors the opportunity to lock in the price which can help the corporate CFO by eliminating balance-sheet volatility, providing budget certainty, and removing the costs involved in managing an asset management function. 

    “It takes the uncertainty off the table,” said Jake Pringle, Principal and Consulting Actuary at consultancy Milliman.  

    “When you buy-in, you know the price up front before you do any other transactions. You are essentially hiring an insurance company to be your liability-driven investment manager.”  

    An earlier deterrent to buy-ins was their relatively higher cost at a time when DB schemes were not as well funded as they are now. With the average plan now estimated to be 104.6% funded and armed with the knowledge gained by completing buy-in transactions in recent years, life insurers in the US have a greater appetite for the product. 

    “The market has done 30 or so of those transactions, if not more, and through those iterations a lot of experience has been gained,” said Alex Gagnon, Head of Distribution at Legal & General Retirement America. 

    “They’ve worked through some of the kinks and so the product today is more streamlined than it was five years ago, which is also easier to market to sponsors and easier for them to understand.” 

    The higher funding levels of DB schemes in the US seen in recent years have also likely had an impact on demand for buy-in solutions, as the speed at which they can be completed provides something of a hedge against falling interest rates, a trend that began in the US in August 2024 and resumed in September this year with a 25 basis points cut; other things being equal, higher interest rates mean lower prices, and vice versa. 

    And whilst buy-ins may not be the holy grail to a US corporate CFO, Gagnon says the time to buy-out is decreasing, so any additional costs of a buy-in transaction – namely, the administration costs that the plan sponsor continues to incur between when the buy-in transaction is completed and when the buy-out gets finalised – are mitigated to a certain extent. 

    “The new buy-in structures that we have seen in the market do tend to be converted into a buy-out within a year or two from buy-in execution so whatever added costs the buy-in entails vs. the buy-out are only for a short period of time.” 

    The US pension risk transfer market has pulled back quite significantly this year. Total PRT new premium fell 64% in the second quarter of 2025 to $4.1bn, according to LIMRA’s U.S. Group Annuity Risk Transfer Sales Survey. Through the first half of the year, total PRT sales were $11.5bn, down 56% year over year. 

    That has impacted on the buy-in market, of course. LIMRA’s survey says that in the first six months of 2025, buy-in sales were $404.8m, down 82%, but US carriers reported five buy-in contracts, equal to the number of contracts sold during the same period in 2024. 

    PRT data tends to be reported with a lag, however; LIMRA published the aforementioned data towards the end of September but now, with the fourth quarter of 2025 well underway, Gagnon says that, when the year is all said and done, buy-ins could account for their largest proportion of the market to date. 

    “If you look at the last few years, buy-ins represented something between 5% and 10% of the total premium market. Well, through September, that’s already just under 15%; so, we are seeing a trend upwards,” he said. 

    “I would be surprised if we didn’t get close to 20 buy-ins this year, which would be double what we’ve seen in the past.” 

    2025 - November Longevity Risk Pension Risk Transfer Volume 1 Issue 2 – November 2025
    Share. Twitter LinkedIn Email

    Related Posts

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026By Greg Winterton

    Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

    August 5, 2026By LMI Newsdesk

    Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 3, 2026By LMI Newsdesk

    Lincoln Financial Reinsures Universal Life Block With Talcott

    August 3, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.